Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve

NCT02268032 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Women
Infertility, Female

Interventions

DRUG: DHEA
DRUG: Another Androgenic Agent (VRaA)
DRUG: Fixed combination of 2 androgenic agents (VR2A)

Sponsor

Laboratorios Andromaco S.A.